Literature DB >> 9129657

Human immunodeficiency virus type 1 Vpu modifies viral cytopathic effect through augmented virus release.

Y Iwatani1, S K Song, L Wang, J Planas, H Sakai, A Ishimoto, M W Cloyd.   

Abstract

We characterized two human immunodeficiency virus type 1 (HIV-1) strains, HIVMCK and HIV213, which have different cytopathic effects in infected cells. HIV213 was highly cytopathic, whereas HIVMCK was not. Biological analyses of chimeric viruses from the cloned infectious DNAs of HIVMCK and HIV213 showed that the Vpu region was responsible for the differing cytopathicity of these viruses. Although HIVMCK expressed Vpu protein, HIV213 did not because of a mutation at the start codon for Vpu. The amounts of envelope glycoprotein and virus particles associated with the cell surface were significantly increased on cells infected with Vpu-deficient viruses compared with Vpu-positive viruses. These data suggest that the highly cytopathic effects of HIV213 (Vpu-deficient) are due to an accumulation of envelope glycoprotein at the infected-cell surface, which would be caused by the retention of progeny virions in the absence of Vpu-facilitated virion release.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9129657     DOI: 10.1099/0022-1317-78-4-841

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  2 in total

1.  Specific VpU codon changes were significantly associated with gp120 V3 tropic signatures in HIV-1 B-subtype.

Authors:  Salvatore Dimonte; Muhammed Babakir-Mina; Stefano Aquaro; Carlo-Federico Perno
Journal:  Virol Sin       Date:  2012-12-28       Impact factor: 4.327

2.  Prolonged persistence of a novel replication-defective HIV-1 variant in plasma of a patient on suppressive therapy.

Authors:  Samantha Rassler; Roberto Ramirez; Nadeen Khoury; Gail Skowron; Gautam K Sahu
Journal:  Virol J       Date:  2016-09-21       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.